Juliane Bernholz is the founder of AM Pharma. AM Pharma has raised $133M in total funding.
Juliane Bernholz is the Chief Executive Officer of AM Pharma, a clinical-stage biotech company in the Netherlands. She has been involved in the development of treatments for rare and critical care diseases, including Hypophosphatasia and Acute Kidney Injury.
Full founder directory · Investor directory · Company funding database · Fundraising library